Clinical insights into extracellular vesicles for targeted myocardial drug delivery

Introduction The heart is a highly dynamic organ with limited regenerative capacity and a unique microvascular environment, which restricts the accumulation and retention of systemically administered therapeutics. Despite notable progress in nanomedicine and targeted drug delivery technologies, achieving efficient and specific drug delivery to cardiac tissue remains a formidable challenge.